Progress in the mechanism and targeted drug therapy for COPD
C Wang, J Zhou, J Wang, S Li, A Fukunaga… - … and Targeted Therapy, 2020 - nature.com
Chronic obstructive pulmonary disease (COPD) is emphysema and/or chronic bronchitis
characterised by long-term breathing problems and poor airflow. The prevalence of COPD …
characterised by long-term breathing problems and poor airflow. The prevalence of COPD …
The GOLD Summit on chronic obstructive pulmonary disease in low-and middle-income countries
Chronic obstructive pulmonary disease (COPD) is one of the top three causes of death
worldwide, but governments and non-governmental organisations have not given its …
worldwide, but governments and non-governmental organisations have not given its …
Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary |
European Respiratory Society Skip to main content Top Menu ERS website Respiratory …
European Respiratory Society Skip to main content Top Menu ERS website Respiratory …
Impact and prevention of severe exacerbations of COPD: a review of the evidence
DMG Halpin, M Miravitlles, N Metzdorf… - International journal of …, 2017 - Taylor & Francis
Severe exacerbations of COPD, ie, those leading to hospitalization, have profound clinical
implications for patients and significant economic consequences for society. The prevalence …
implications for patients and significant economic consequences for society. The prevalence …
Estimated emergency and observational/quarantine capacity need for the US homeless population related to COVID-19 exposure by county; projected …
This report estimates the potential hospitalization, ICU use and mortality rates associated
with COVID-19 infection among the homeless population in the United States, as well as …
with COVID-19 infection among the homeless population in the United States, as well as …
Pulmonary hypertension associated with lung diseases
OA Shlobin, Y Adir, JA Barbera… - European …, 2024 - publications.ersnet.org
Pulmonary hypertension (PH) associated with chronic lung disease (CLD) is both common
and underrecognised. The presence of PH in the setting of lung disease has been …
and underrecognised. The presence of PH in the setting of lung disease has been …
Continuing to confront COPD international patient survey: economic impact of COPD in 12 countries
J Foo, SH Landis, J Maskell, YM Oh, T Van Der Molen… - PloS one, 2016 - journals.plos.org
Background The Continuing to Confront COPD International Patient Survey estimated the
prevalence and burden of COPD across 12 countries. Using data from this survey we …
prevalence and burden of COPD across 12 countries. Using data from this survey we …
[HTML][HTML] Direct and indirect costs of COPD and its comorbidities: results from the German COSYCONET study
Background Reliable up-to-date estimates regarding the economic impact of chronic
obstructive pulmonary disease (COPD) are lacking. This study investigates COPD excess …
obstructive pulmonary disease (COPD) are lacking. This study investigates COPD excess …
Gold 2023: Highlights for primary care
A Agustí, A Sisó-Almirall, M Roman… - NPJ primary care …, 2023 - nature.com
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has issued its 2023
annual report 1. Compared with former versions, it has been significantly updated. Here, we …
annual report 1. Compared with former versions, it has been significantly updated. Here, we …
A review of nebulized drug delivery in COPD
DP Tashkin - … Journal of Chronic Obstructive Pulmonary Disease, 2016 - Taylor & Francis
Current guidelines recommend inhaled pharmacologic therapy as the preferred route of
administration for treating COPD. Bronchodilators (β2-agonists and antimuscarinics) are the …
administration for treating COPD. Bronchodilators (β2-agonists and antimuscarinics) are the …